ArticleOncoimmunology2022

Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity.

Yuan-Na Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.